January 30, 2020
CloudLIMS, a bronze sponsor of the Biobanking International Symposium, is excited to announce its participation in the event, to be held at the Institute of Liver and Biliary Sciences, New Delhi, India, from February 20-21, 2020. Attendees from across the globe are expected to attend the event. CloudLIMS is a secure, SaaS, in the cloud LIMS with zero upfront cost, purpose-built for biobanks. CloudLIMS helps biobanks manage samples and metadata, locate stored samples, automate and streamline workflows, remove data silos, and follow guidelines and standards such as ISO 20387:2018, EU GDPR, HIPAA, 21 CFR Part 11, and ISBER Best Practices. Our COO, Shonali Paul, is participating in the event. If you would like to discuss the data management, automation, or regulatory challenges of your biobank, schedule a meeting with us to find out how CloudLIMS can help to mitigate the challenges.
The two-day event includes a symposium and a half-day workshop followed by an open forum by ISBER titled: Strengthening the future of biobanking in India by engaging the world through ISBER: A Discussion. The half-day workshop provides hands-on training in sample collection, processing, storage, and retrieval. The open forum emphasizes the opportunities and challenges of biobanks in India, Quality Control, data management, and biobank sustainability. The symposium brings together technical experts, renowned scientists, clinicians, and leaders from the biobanking, pharmaceutical and biotechnology industry for disseminating knowledge, ideas, and expertise through interactive sessions and informative presentations. The agenda includes keynotes on biospecimen collection and management, and presentations by Indian and international leaders in biospecimen-based research. The event provides an excellent platform for attendees to learn best practices in biobanking, legal and ethical issues in biobanking, and new technologies and trends in the global biobanking sector.
We look forward to seeing you in New Delhi.
Also, read the case study titled “RGCI & RC uses CloudLIMS to Manage Breast Cancer Research”.